Cutaneous and uveal melanoma: two different cancers in therapeutic needs

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Melanocytes in skin and eyes can transform into melanoma, a dangerous cancer.
• Cutaneous and uveal melanomas differ genetically, in metastasis, and treatment response.
• Current treatments for metastatic melanoma show limited success, highlighting a need for new therapies.

Purpose of the Study:

• To review recent advances in understanding melanoma genetics and molecular pathways.
• To discuss the role of MITF gene mutations in cutaneous melanoma predisposition.
• To explore intratumor heterogeneity and cell subpopulations in uveal melanoma.

Main Methods:

• Literature review of genetic and genomic studies in melanoma.
• Analysis of molecular alterations, including gene mutations and cellular heterogeneity.
• Synthesis of findings related to melanocyte homeostasis and melanoma development.

Main Results:

• MITF identified as a melanoma predisposition gene in cutaneous melanoma due to mutations.
• Intratumor heterogeneity and distinct cell subpopulations characterized in primary uveal melanomas.
• Significant differences in genetic alterations and therapeutic responses between cutaneous and uveal melanoma highlighted.

Conclusions:

• Understanding melanoma heterogeneity and genetic drivers like MITF is crucial for therapeutic development.
• New insights provide potential tools for early detection and novel therapeutic targets for both melanoma types.
• Addressing treatment failure in metastatic melanoma requires further research into distinct tumor characteristics.